Rezolute, Inc. Common Stock (NV) (RZLT) News

Latest headlines that mention RZLT, newest first · each headline opens the original publisher

RZLT quote

Last price: $4.04
Day change: +0.37%
Next earnings: —

Quote & chart Expected move Insider trading IV rank history

RZLT headlines

latest coverage

Investing.com 2d ago

Rezolute at Guggenheim: FDA progress lifts rare-disease hopes

General T3RZLT

Seeking Alpha 5d ago

Rezolute GAAP EPS of -$0.18 in-line

Earnings T2RZLT

Seeking Alpha 1mo ago

Rezolute upgraded at Cantor on pre-BLA meeting for ersodetug

General T2RZLT

Investing.com 1mo ago

Citizens raises Rezolute stock price target on FDA feedback

General T3RZLT

Investing.com 1mo ago

Citizens reiterates Rezolute stock rating on tumor trial results due

General T3RZLT

Seeking Alpha 1mo ago

Rezolute GAAP EPS of -$0.20 misses by $0.05

Earnings T2RZLT

Seeking Alpha News 2mo ago

Rezolute: Initiating At Sell Despite Attempts To Rescue Ersodetug Following sunRIZE Upset

General T2RZLT

Seeking Alpha 2mo ago

Rezolute says late-stage trial data for lead asset remains under FDA review

General T2RZLT

Investing.com 2mo ago

Rezolute awaits FDA feedback on congenital HI treatment data

General T3RZLT

Investing.com 4mo ago

Form 4 Rezolute Inc For: 7 July

General T3RZLT

Seeking Alpha 5mo ago

Rezolute upgraded at Citizens after late-stage trial data for lead asset

General T2RZLT

Investing.com 5mo ago

Cantor Fitzgerald reiterates Neutral on Rezolute stock on trial data

General T3RZLT

Seeking Alpha 5mo ago

Rezolute rises after late-stage trial update

General T2RZLT

Investing.com 5mo ago

Rezolute reports interim data from tumor hyperinsulinism trial

General T3RZLT

Investing.com 6mo ago

H.C. Wainwright reiterates Buy on Rezolute stock, $5 target

General T3RZLT

RZLT news alerts

Get an alert by email or push when a new headline mentions RZLT.

More news

News headlines aggregated from third-party publishers via public RSS feeds and tagged with the tickers they mention. Frenzy Capital does not publish or endorse the content; clicking a headline opens the original publisher in a new tab.